These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19781296)

  • 1. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases.
    Ma XW; Chang ZW; Qin MZ; Sun Y; Huang HL; He Y
    Chin Med J (Engl); 2009 Sep; 122(18):2123-8. PubMed ID: 19781296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
    Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
    Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets.
    Hernández-Campo PM; Martín-Ayuso M; Almeida J; López A; Orfao A
    Cytometry; 2002 Jun; 50(3):191-201. PubMed ID: 12116342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes.
    Christmas SE; de la Mata Espinosa CT; Halliday D; Buxton CA; Cummerson JA; Johnson PM
    Immunology; 2006 Dec; 119(4):522-8. PubMed ID: 16999828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans.
    Amara U; Kalbitz M; Perl M; Flierl MA; Rittirsch D; Weiss M; Schneider M; Gebhard F; Huber-Lang M
    Shock; 2010 Jun; 33(6):568-75. PubMed ID: 19864971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.
    Alegretti AP; Mucenic T; Merzoni J; Faulhaber GA; Silla LM; Xavier RM
    Cell Immunol; 2010; 265(2):127-32. PubMed ID: 20727519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction.
    Malecki MT; Osmenda G; Walus-Miarka M; Skupien J; Cyganek K; Mirkiewicz-Sieradzka B; damek-Guzik TA; Guzik TJ; Sieradzki J
    Eur J Clin Invest; 2008 Dec; 38(12):925-30. PubMed ID: 19021717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
    Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
    Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
    Terpos E; Sarantopoulos A; Kouramba A; Katsarou O; Stavropoulos J; Masouridi S; Karafoulidou A; Meletis J
    Med Sci Monit; 2008 May; 14(5):CR276-280. PubMed ID: 18443552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins.
    Ohi H; Tamano M; Sudo S; Okada N
    Am J Kidney Dis; 2003 Jan; 41(1):179-85. PubMed ID: 12500235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias.
    Ruiz-Argüelles A; Llorente L
    Autoimmun Rev; 2007 Jan; 6(3):155-61. PubMed ID: 17289551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Number and function of circulating endothelial progenitor cell in diabetics with different vascular complications].
    Chen LL; Liao YF; Zeng TS; Li YM; Yu F; Li HQ
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1234-9. PubMed ID: 19595175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid intima-media thickness in type 2 diabetes is more strongly related to serum apoprotein A-I in females.
    Tkác I; Mudríková T; Szabóova E; Durovcová E; Lewis GF
    Wien Klin Wochenschr; 2001 Mar; 113(5-6):194-8. PubMed ID: 11293949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells).
    Solomon KR; Chan M; Finberg RW
    Cell Immunol; 1995 Oct; 165(2):294-301. PubMed ID: 7553895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S; Vasilescu R
    Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of atorvastatin on the expression of CD55, CD59 in patients with hyperlipidemia].
    Liu YM; He JC; Yang JG; Liu YY; Yan X; Zhao L; Ma XW; Shang DY; Qiao CD; Li WX; Wang JY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1075-9. PubMed ID: 16563273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
    Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
    Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of CD46 and CD59 on leukocytes in neovascular age-related macular degeneration.
    Singh A; Faber C; Falk M; Nissen MH; Hviid TV; Sørensen TL
    Am J Ophthalmol; 2012 Jul; 154(1):193-199.e2. PubMed ID: 22541656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
    Clayton A; Harris CL; Court J; Mason MD; Morgan BP
    Eur J Immunol; 2003 Feb; 33(2):522-31. PubMed ID: 12645951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
    Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
    Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.